Tranzyme Pharma Promotes David Moore to Chief Business Officer
[at noodls] – RESEARCH TRIANGLE PARK, N.C., Jan. 15, 2013 (GLOBE NEWSWIRE) — Tranzyme Pharma (Nasdaq:TZYM) today announced that David S. Moore has been named as Chief Business Officer….This is an abstract of the … more
View todays social media effects on OCRX
View the latest stocks trending across Twitter. Click to view dashboard